Status:
COMPLETED
Effects of Omega 3 in Hemodialysis Patients
Lead Sponsor:
Laboratoire Régional de Nutrition Humaine
Conditions:
Hemodialysis
End Stage Renal Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.
Eligibility Criteria
Inclusion
- hemodialysis at least 6 months duration end stage renal disease
Exclusion
- \- Age \< 18 y ou \> 75 y
- Hemodialysis \< 6 months
- Diabetes, obesity
- allergy to fish
- Asthma
- glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin
- erythropoïetin \< 3 months
- Cancer
- Hemoglobin \< 11 g/l
- disease \< 1 month
- pregnancy
- respiratory insufficiency
- intensive sport practice
- refusal
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
End Date :
November 1 2003
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00431899
Start Date
May 1 2003
End Date
November 1 2003
Last Update
March 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire Régional de Nutrition Humaine
Brest, France, F-29200